ZANLISTIQ Trademark

Trademark Overview


On Friday, March 1, 2013, a trademark application was filed for ZANLISTIQ with the United States Patent and Trademark Office. The USPTO has given the ZANLISTIQ trademark a serial number of 85864149. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 3, 2016. This trademark is owned by Eli Lilly and Company. The ZANLISTIQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders, sleep disorders, urological disorders; antidepressants
zanlistiq

General Information


Serial Number85864149
Word MarkZANLISTIQ
Filing DateFriday, March 1, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 3, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 2, 2013

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders, sleep disorders, urological disorders; antidepressants
Translation of Words in MarkThe wording "ZANLISTIQ" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 7, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Monday, October 3, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 3, 2016ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 15, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, December 12, 2015EXTENSION 5 GRANTED
Wednesday, December 9, 2015EXTENSION 5 FILED
Wednesday, December 9, 2015TEAS EXTENSION RECEIVED
Tuesday, August 18, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 17, 2015EXTENSION 4 GRANTED
Thursday, July 16, 2015EXTENSION 4 FILED
Thursday, July 16, 2015TEAS EXTENSION RECEIVED
Friday, December 12, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 11, 2014EXTENSION 3 GRANTED
Monday, December 8, 2014EXTENSION 3 FILED
Monday, December 8, 2014TEAS EXTENSION RECEIVED
Saturday, July 12, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 11, 2014EXTENSION 2 GRANTED
Monday, July 7, 2014EXTENSION 2 FILED
Monday, July 7, 2014TEAS EXTENSION RECEIVED
Tuesday, March 4, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 3, 2014EXTENSION 1 GRANTED
Wednesday, February 5, 2014EXTENSION 1 FILED
Sunday, March 2, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 5, 2014TEAS EXTENSION RECEIVED
Tuesday, August 27, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 2, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 2, 2013PUBLISHED FOR OPPOSITION
Wednesday, June 12, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 24, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 23, 2013ASSIGNED TO EXAMINER
Thursday, March 7, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, March 5, 2013NEW APPLICATION ENTERED IN TRAM